HBV reactivation is concern with DAA Tx in HBV-HCV coinfection
(HealthDay)—Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published ...
Apr 25, 2017
0
0